Trio Petroleum Corp
TPET NYSE Crude Petroleum & Natural Gas Financials FY2022βFY2025
What Trio Petroleum Corp does
No business description yet.
- Legal name
- Trio Petroleum Corp
- Fiscal year ends
- October 31, 2025
- Latest annual report
- 10-K Β· Jan 20, 2026
- Accession Β· CIK
- 0001493152-26-002848
0001898766
Revenue and margins
Trio Petroleum Corp had $0.0M of revenue in fiscal 2025, down 85.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Trio Petroleum Corp returned β to shareholders in fiscal 2025. The diluted share count rose 309.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Trio Petroleum Corp can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.1M | $1.6M | $0.3M | $0.9M |
| Interest coverage | β0.5x | β5.8x | β2.9x | β8.7x |
| Current ratio | 0.3x | 0.9x | 0.2x | 0.6x |
| Quick ratio | 0.3x | 0.9x | 0.2x | 0.6x |
| Total assets | $9.5M | $11.6M | $11.7M | $13.2M |
| Total liabilities | $6.8M | $1.9M | $2.6M | $1.9M |
| Shareholders' equity | $2.7M | $9.7M | $9.0M | $11.3M |
| Net debt (β = net cash) | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | 4 / 8 |
| Accruals ratio | β34.8% | β23.7% | β49.6% | β37.6% |
| Altman Z'' | β4.92 | β0.29 | β6.72 | β3.61 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | β | β | $0.2M | $0.0M |
| Net interest income | β | β | β | $0.0M |
| Gross profit | β | β | $0.2M | $0.2M |
| Operating income | β$0.8M | β$4.6M | β$6.2M | β$5.3M |
| Interest expense | $1.7M | $0.8M | $2.1M | $0.6M |
| Pretax income | β$3.8M | β$6.5M | β$9.6M | β$7.3M |
| Net income | β$3.8M | β$6.5M | β$9.6M | β$7.3M |
| Diluted EPS | β$0.26 | β$5.67 | β$4.32 | β$0.80 |
| Diluted shares | 0.01B | 0.00B | 0.00B | 0.01B |
| Cash flow | ||||
| Cash from operations | β$0.5M | β$4.0M | β$3.8M | β$2.6M |
| Stock-based compensation | $0.0M | $1.0M | $1.5M | $2.6M |
| Balance sheet | ||||
| Cash and short-term investments | $0.1M | $1.6M | $0.3M | $0.9M |
| Current assets | $1.8M | $1.7M | $0.6M | $1.1M |
| Current liabilities | $6.7M | $1.9M | $2.6M | $1.9M |
| Total assets | $9.5M | $11.6M | $11.7M | $13.2M |
| Total liabilities | $6.8M | $1.9M | $2.6M | $1.9M |
| Shareholders' equity | $2.7M | $9.7M | $9.0M | $11.3M |
| Margins | ||||
| Gross margin | β | β | 100.0% | 743.3% |
| Operating margin | β | β | β2,916.4% | β17,573.7% |
| Net margin | β | β | β4,515.4% | β24,273.7% |
| Net interest share of revenue | β | β | β | 92.0% |
| Returns | ||||
| Return on capital employed | β29.0% | β47.1% | β68.4% | β46.4% |
| Return on equity | β139.6% | β105.0% | β102.5% | β71.6% |
| Return on assets | β40.1% | β61.9% | β82.5% | β58.5% |
| Return on tangible equity | β139.6% | β67.2% | β106.5% | β64.4% |
| Growth | ||||
| Revenue growth | β | β | β | β85.9% |
| Share count change | β | β92.2% | 92.9% | 309.5% |
| Financial health | ||||
| Interest coverage | β0.5x | β5.8x | β2.9x | β8.7x |
| Current ratio | 0.3x | 0.9x | 0.2x | 0.6x |
| Quick ratio | 0.3x | 0.9x | 0.2x | 0.6x |
| Capital allocation | ||||
| Stock comp / revenue | β | β | 719.8% | 8,763.7% |
| Quality scores | ||||
| Piotroski F-score | β | β | β | 4.0 |
| Altman Z'' | β4.9 | β0.3 | β6.7 | β3.6 |
| Accruals ratio | β34.8% | β23.7% | β49.6% | β37.6% |
Source: SEC EDGAR XBRL filings (CIK 0001898766). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.